산전 검사 및 신생아 스크리닝 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Prenatal Testing & Newborn Screening Trends and Forecast

The future of the global prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets. The global prenatal testing & newborn screening market is expected to reach an estimated $10.8 billion by 2030 with a CAGR of 12.8% from 2024 to 2030. The major drivers for this market are growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.

A more than 150-page report is developed to help in your business decisions.

Prenatal Testing & Newborn Screening by Segment

The study includes a forecast for the global prenatal testing & newborn screening by diagnostic type, technology, end use, and region.

Prenatal Testing & Newborn Screening Market by Diagnostic Type [Shipment Analysis by Value from 2018 to 2030]:

• Invasive
• Non-Invasive

Prenatal Testing & Newborn Screening Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Screening Technology
• Diagnostic Technology

Prenatal Testing & Newborn Screening Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Others

Prenatal Testing & Newborn Screening Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Prenatal Testing & Newborn Screening Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies prenatal testing & newborn screening companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prenatal testing & newborn screening companies profiled in this report include-

• Perkinelmer
• Natera
• Invitae
• Centogene
• Cradle Genomics
• Hoffmann-La Roche
• Quest Diagnostics
• Baebies
• Ravgen
• Eurofins Scientific

Prenatal Testing & Newborn Screening Market Insights

Lucintel forecasts that non-invasive is expected to witness higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.

Hospital is expected to witness higher growth over the forecast perioddue to growing patients preference for this facility to make informed decisions.

North America is expected to witness highest growth over the forecast period due to growing number of genetic disorders cases and presence of favourable reimbursement policy in the region.

Features of the Global Prenatal Testing & Newborn Screening Market

Market Size Estimates: Prenatal testing & newborn screening market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Prenatal testing & newborn screening market size by diagnostic type, technology, end use, and region. in terms of value ($B).

Regional Analysis: Prenatal testing & newborn screening market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic types, technologies, end uses, and region.s for the prenatal testing & newborn screening market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the prenatal testing & newborn screening market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the prenatal testing & newborn screening market size?

Answer: The global prenatal testing & newborn screening market is expected to reach an estimated $10.8 billion by 2030.

Q.2. What is the growth forecast for prenatal testing & newborn screening market?

Answer: The global prenatal testing & newborn screening market is expected to grow with a CAGR of 12.8% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the prenatal testing & newborn screening market?

Answer: The major drivers for this market are growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.

Q.4. What are the major segments for prenatal testing & newborn screening market?

Answer: The future of the prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets.

Q.5. Who are the key prenatal testing & newborn screening market companies?

Answer: Some of the key prenatal testing & newborn screening companies are as follows:

• PerkinElmer
• Natera
• Invitae
• Centogene
• Cradle Genomics
• Hoffmann-La Roche
• Quest Diagnostics
• Baebies
• Ravgen
• Eurofins Scientific

Q.6. Which prenatal testing & newborn screening market segment will be the largest in future?

Answer: Lucintel forecasts that non-invasive is expected to witness higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.

Q.7. In prenatal testing & newborn screening market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing number of genetic disorders cases and presence of favourable reimbursement policy in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the prenatal testing & newborn screening market by diagnostic type (invasive and non-invasive), technology (screening technology and diagnostic technology), end use (hospitals, diagnostic centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Prenatal Testing & Newborn Screening Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Prenatal Testing & Newborn Screening Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Prenatal Testing & Newborn Screening Market by Diagnostic Type
  • 3.3.1: Invasive
  • 3.3.2: Non-Invasive
• 3.4: Global Prenatal Testing & Newborn Screening Market by Technology
  • 3.4.1: Screening Technology
  • 3.4.2: Diagnostic Technology
• 3.5: Global Prenatal Testing & Newborn Screening Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostic Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Prenatal Testing & Newborn Screening Market by Region
• 4.2: North American Prenatal Testing & Newborn Screening Market
  • 4.2.2: North American Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.3: European Prenatal Testing & Newborn Screening Market
  • 4.3.1: European Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
  • 4.3.2: European Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.4: APAC Prenatal Testing & Newborn Screening Market
  • 4.4.1: APAC Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
  • 4.4.2: APAC Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.5: ROW Prenatal Testing & Newborn Screening Market
  • 4.5.1: ROW Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
  • 4.5.2: ROW Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Diagnostic Type
  • 6.1.2: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Technology
  • 6.1.3: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by End Use
  • 6.1.4: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Region
• 6.2: Emerging Trends in the Global Prenatal Testing & Newborn Screening Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Prenatal Testing & Newborn Screening Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Prenatal Testing & Newborn Screening Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: PerkinElmer
• 7.2: Natera
• 7.3: Invitae
• 7.4: Centogene
• 7.5: Cradle Genomics
• 7.6: Hoffmann-La Roche
• 7.7: Quest Diagnostics
• 7.8: Baebies
• 7.9: Ravgen
• 7.10: Eurofins Scientific